A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With...
Erectile DysfunctionThe objective of this study was to evaluate the efficacy and tolerability of the phosphodiesterase type 5 inhibitor (PDE5 inhibitor), vardenafil, in a broad population of subjects with erectile dysfunction of different aetiologies and severity, who have not been previously treated with a PDE5 inhibitor; Efficacy and safety was compared with placebo.
Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of...
Erectile DysfunctionThis study investigates the safety and efficacy of a new dosage form of Vardenafil, an orodispersible tablet (ODT), and compares it to the safety and efficacy of a placebo (inactive) tablet in the treatment of erectile dysfunction. After a 4-week unmedicated phase, patients will receive Vardenafil ODT or matching placebo for 12 weeks. Safety will be determined by laboratory and other evaluations. Efficacy will be determined by the results of different questionnaires and the patient diary that will be used.
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury...
Erectile DysfunctionSpinal Cord InjuriesThis is a study of the efficacy and safety of on-demand dosing of tadalafil or placebo administered for 12 weeks to men with erectile dysfunction caused by spinal cord injury.
Phase I Study to Investigate the Alcohol Interaction of SK3530
Erectile DysfunctionThis study was designed to investigate the alcohol effect of SK3530 on the pharmacokinetics (PKs) and safety.
Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining...
ImpotenceTo determine if men prefer tadalafil or sildenafil for getting and keeping an erection after treatment with both drugs.
To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours...
ImpotenceStudy to see how effective different doses of tadalafil are for getting and keeping an erection when sex is attempted after a certain number of hours.
A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify....
ImpotenceTo compare the efficacy and safety of Viagra (sildenafil citrate) vs. placebo for the treatment of men with ED and at least 1 prespecified risk factor who do not self identify as having ED.
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole...
Seizure DisorderHypogonadism1 moreThe purpose of this study is to determine if treatment using a medication (anastrozole/Arimidex), which lowers estrogen levels in the blood is better than placebo, a tablet that does not contain any active medication, when combined with testosterone replacement to treat reproductive and sexual dysfunction in men with epilepsy. Anastrozole, the medication that is currently under study, does not, at this time, have FDA approval for use for this indication.
Evaluation of the Index of Sexual Life Questionnaire
ImpotenceThe purpose of the study is to assess the sensibility of the ISL questionnaire.
Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?...
Prostate CancerErectile DysfunctionBecause of the high incidence of post-radiation erectile dysfunction (ED), up to 72% after external-beam radiotherapy, this patient category represents a most difficult therapeutic challenge. Therefore, prevention of ED could be more effective than treatment. Tadalafil, a new phosphodiesterase type 5 inhibitor, has been recently introduced. No studies have investigated the efficacy of tadalafil in preventing ED in patients undergoing radiotherapy for prostate cancer. Efficacy of tadalafil can last up to 36 hours after intake. This will result in a prolonged and continuos enhancement of penile vascular responsiveness. This randomized, double-blind, placebo-controlled study has been designed to evaluate the efficacy of 20-mg of tadalafil administered for 12 months in maintaining erectile function of potent patients undergoing external-beam radiotherapy for prostate cancer.